These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30624178)

  • 1. Defining of MAbs-neutralizing sites on the surface glycoproteins Gn and Gc of a hantavirus using vesicular stomatitis virus pseudotypes and site-directed mutagenesis.
    Levanov L; Iheozor-Ejiofor RP; Lundkvist Å; Vapalahti O; Plyusnin A
    J Gen Virol; 2019 Feb; 100(2):145-155. PubMed ID: 30624178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of an antigenic site targeted by monoclonal antibodies against Puumala virus.
    Plyusnin A; Kedari A; Rissanen I; Iheozor-Ejiofor RP; Lundkvist Å; Vapalahti O; Levanov L
    J Gen Virol; 2023 Oct; 104(10):. PubMed ID: 37801017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Antibody Interactions with the G Protein of Vesicular Stomatitis Virus Indiana Strain and Other Vesiculovirus G Proteins.
    Munis AM; Tijani M; Hassall M; Mattiuzzo G; Collins MK; Takeuchi Y
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model.
    Duehr J; McMahon M; Williamson B; Amanat F; Durbin A; Hawman DW; Noack D; Uhl S; Tan GS; Feldmann H; Krammer F
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors.
    Slough MM; Chandran K; Jangra RK
    mBio; 2019 Jan; 10(1):. PubMed ID: 30622188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by a vaccinia virus vector.
    Keil W; Wagner RR
    Virology; 1989 Jun; 170(2):392-407. PubMed ID: 2471352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin A responses to Puumala hantavirus.
    de Carvalho Nicacio C; Björling E; Lundkvist A
    J Gen Virol; 2000 Jun; 81(Pt 6):1453-61. PubMed ID: 10811929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus (New Jersey serotype): a method for preliminary mapping of epitopes.
    Bricker BJ; Snyder RM; Fox JW; Volk WA; Wagner RR
    Virology; 1987 Dec; 161(2):533-40. PubMed ID: 2446424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular insight into the neutralization mechanism of human-origin monoclonal antibody AH100 against Hantaan virus.
    Wang F; Liu T; Liao L; Chai Y; Qi J; Gao F; Liang M; Gao GF; Wu Y
    J Virol; 2024 Aug; 98(8):e0088324. PubMed ID: 39078157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.
    Shih YP; Chen CY; Liu SJ; Chen KH; Lee YM; Chao YC; Chen YM
    J Virol; 2006 Nov; 80(21):10315-24. PubMed ID: 17041212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Basis for a Neutralizing Antibody Response Elicited by a Recombinant Hantaan Virus Gn Immunogen.
    Rissanen I; Krumm SA; Stass R; Whitaker A; Voss JE; Bruce EA; Rothenberger S; Kunz S; Burton DR; Huiskonen JT; Botten JW; Bowden TA; Doores KJ
    mBio; 2021 Aug; 12(4):e0253120. PubMed ID: 34225492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfide-bonded discontinuous epitopes on the glycoprotein of vesicular stomatitis virus (New Jersey serotype).
    Grigera PR; Keil W; Wagner RR
    J Virol; 1992 Jun; 66(6):3749-57. PubMed ID: 1374811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of chimeric virus-like particles harbouring a segment of hantavirus Gc glycoprotein to generate a broadly-reactive hantavirus-specific monoclonal antibody.
    Zvirbliene A; Kucinskaite-Kodze I; Razanskiene A; Petraityte-Burneikiene R; Klempa B; Ulrich RG; Gedvilaite A
    Viruses; 2014 Feb; 6(2):640-60. PubMed ID: 24513568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses.
    Mittler E; Wec AZ; Tynell J; Guardado-Calvo P; Wigren-Byström J; Polanco LC; O'Brien CM; Slough MM; Abelson DM; Serris A; Sakharkar M; Pehau-Arnaudet G; Bakken RR; Geoghegan JC; Jangra RK; Keller M; Zeitlin L; Vapalahti O; Ulrich RG; Bornholdt ZA; Ahlm C; Rey FA; Dye JM; Bradfute SB; Strandin T; Herbert AS; Forsell MNE; Walker LM; Chandran K
    Sci Transl Med; 2022 Mar; 14(636):eabl5399. PubMed ID: 35294259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of amino acids involved in a serotype and neutralization specific epitope within the s1 subunit of avian infectious bronchitis virus.
    Moore KM; Jackwood MW; Hilt DA
    Arch Virol; 1997; 142(11):2249-56. PubMed ID: 9672590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GP4-specific neutralizing antibodies might be a driving force in PRRSV evolution.
    Costers S; Vanhee M; Van Breedam W; Van Doorsselaere J; Geldhof M; Nauwynck HJ
    Virus Res; 2010 Dec; 154(1-2):104-13. PubMed ID: 20837070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell epitopes of the envelope glycoprotein of caprine arthritis-encephalitis virus and antibody response in infected goats.
    Bertoni G; Hertig C; Zahno ML; Vogt HR; Dufour S; Cordano P; Peterhans E; Cheevers WP; Sonigo P; Pancino G
    J Gen Virol; 2000 Dec; 81(Pt 12):2929-2940. PubMed ID: 11086124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of neutralization sites on the circulating variant of swine vesicular disease virus (SVDV): a new site is shared by SVDV and the related coxsackie B5 virus.
    Borrego B; Carra E; García-Ranea JA; Brocchi E
    J Gen Virol; 2002 Jan; 83(Pt 1):35-44. PubMed ID: 11752698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.
    Fong RH; Banik SS; Mattia K; Barnes T; Tucker D; Liss N; Lu K; Selvarajah S; Srinivasan S; Mabila M; Miller A; Muench MO; Michault A; Rucker JB; Paes C; Simmons G; Kahle KM; Doranz BJ
    J Virol; 2014 Dec; 88(24):14364-79. PubMed ID: 25275138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.